$16.90 +0.15 (0.90%)

Sotera Health Company Common Stock (SHC)

Sotera Health Company (SHC) is a provider of sterilization and lab testing services for the healthcare and pharmaceutical industries. The company specializes in sterilization technologies, including ethylene oxide and gamma irradiation, and offers comprehensive quality control and testing solutions to ensure product safety and compliance. Headquartered in Chicago, Illinois, Sotera Health serves medical device manufacturers, pharmaceutical companies, and other healthcare-related entities worldwide.

🚫 Sotera Health Company Common Stock does not pay dividends

Company News

Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
GlobeNewswire Inc. • N/A • January 6, 2025

Sotera Health Company, a global provider of sterilization solutions and lab services, has appointed Vincent K. Petrella as its new Lead Independent Director, effective January 2, 2025. Petrella, who has served on the company's board since 2020, brings extensive public company leadership experience and will serve as a key liaison between the board...

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Zacks Investment Research • Zacks Equity Research • June 25, 2024

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Expert Ratings For Sotera Health
Benzinga • Benzinga Insights • May 21, 2024

Ratings for Sotera Health (NASDAQ:SHC) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indiffere...

Sotera Health (SHC) Q1 2024 Earnings Call Transcript
The Motley Fool • [email protected] (Motley Fool Transcribing) • May 3, 2024

SHC earnings call for the period ending March 31, 2024.

How to be a contrarian stock investor: This market pro shares his secrets.
MarketWatch • MarketWatch • August 5, 2023

These 3 tactics contribute to this contrarian-minded mutual fund's outperformance.